mRNA |
rigosertib |
CTRPv2 |
pan-cancer |
AAC |
0.02 |
0.6 |
mRNA |
spautin-1 |
CTRPv2 |
pan-cancer |
AAC |
-0.023 |
0.6 |
mRNA |
BRD-K13185470 |
CTRPv2 |
pan-cancer |
AAC |
-0.046 |
0.6 |
mRNA |
tretinoin:navitoclax (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.021 |
0.6 |
mRNA |
selumetinib:tretinoin (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.021 |
0.6 |
mRNA |
CHIR-99021 |
CTRPv2 |
pan-cancer |
AAC |
-0.02 |
0.6 |
mRNA |
decitabine:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.018 |
0.6 |
mRNA |
Bortezomib |
CTRPv2 |
pan-cancer |
AAC |
-0.02 |
0.6 |
mRNA |
Bexarotene |
CTRPv2 |
pan-cancer |
AAC |
0.02 |
0.6 |
mRNA |
PLX4720 |
CTRPv2 |
pan-cancer |
AAC |
-0.019 |
0.6 |